Symbol="KTRA"
AssetType="Common Stock"
Name="Kintara Therapeutics Inc"
Description="Kintara Therapeutics, Inc., a clinical-stage drug development company, focuses on developing and commercializing cancer therapies to treat cancer patients. The company is headquartered in San Diego, California."
CIK="1498382"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="SPECIALTY CLEANING, POLISHING AND SANITATION PREPARATIONS"
Address="722 B KINGSTON ROAD, TORONTO, ON, CA"
FiscalYearEnd="June"
LatestQuarter="2023-03-31"
MarketCapitalization="6024200"
EBITDA="-16845000"
PERatio="None"
PEGRatio="None"
BookValue="-4.054"
DividendPerShare="0"
DividendYield="0"
EPS="-11.27"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-1.082"
ReturnOnEquityTTM="-2.545"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-11.27"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="14"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="7.81"
EVToRevenue="-"
EVToEBITDA="-0.82"
Beta="1.043"
num_52WeekHigh="15.5"
num_52WeekLow="2.7"
num_50DayMovingAverage="4.0"
num_200DayMovingAverage="4.883"
SharesOutstanding="1692200"
DividendDate="2019-05-08"
ExDividendDate="None"
symbol="KTRA"
open="3.78"
high="3.85"
low="3.63"
price="3.73"
volume="4514.00"
latest_trading_day="2023-08-22"
previous_close="3.76"
change="-0.03"
change_percent="-0.7979%"
aroon_positive_momentum_days="66"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="66"
Volume_recent_avg="120916"
Change_recent_avg="0.01"
Delta_recent_avg="0.36"
Variance_recent_avg="0.18"
Change_ratio_recent_avg="-0.32"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="66"
Aroon_momentum_negative="34"
image_negative_thumbnail_id_1="1112"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0145.jpeg"
image_negative_thumbnail_id_2="1145"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0178.jpeg"
image_neutral_thumbnail_id_1="540"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0059.jpeg"
image_neutral_thumbnail_id_2="588"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0011.jpeg"
image_positive_thumbnail_id_1="1003"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0165.jpeg"
image_positive_thumbnail_id_2="689"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0019.jpeg"
image_professor_thumbnail_id_1="1183"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0017.jpeg"
image_professor_thumbnail_id_2="1201"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0035.jpeg"
